Show Menu

A fully integrated developer and manufacturer of polyclonal therapeutics, targeting infectious disease and acute toxic events

News: Archive for December 2016

MicroPharm Secures SMART Grant

MicroPharm Limited announced that it has secured a grant of £195,373 to further support the development of OraCAb, a therapeutic for oral administration of polyclonal antibodies to treat Clostridium difficile infections. This is funding from the European Regional Development Fund (ERDF) under the Welsh government operational programme SMART Cymru West Wales and the Valleys 2014-2020.

Read the full story

Posted on: Thursday, 1st December 2016